Skip to main content
. 2022 Mar 2;12(3):342. doi: 10.3390/brainsci12030342

Table 3.

Effect of purmorphamine on TNF-α and IL-1β level in 8-OH OCD.

S. no. Groups Cytokine Level
TNF-α IL-1β
Brain Homogenate
(pg/mg Protein)
Blood Plasma
(ng/mL)
Brain Homogenate
(pg/mg Protein)
Blood Plasma
(ng/mL)
1. Vehicle control 35.42 ± 0.242 4.49 ± 0.014 18.75 ± 0.126 14.47 ± 0.007
2. Sham control 35.80 ± 0.278 4.50 ± 0.014 18.92 ± 0.318 14.47 ± 0.010
3. PUR10 per se 35.53 ± 0.213 4.49 ± 0.011 18.67 ± 0.291 14.48 ± 0.007
4. 8-OH-DPAT 76.44 ± 0.725 * 9.49 ± 0.009 * 33.22 ± 0.198 * 66.48 ± 0.008 *
5. 8-OH-DPAT + PUR5 67.40 ± 0.657 # 8.47 ± 0.006 # 28.35 ± 0.411 # 55.39 ± 0.012 #
6. 8-OH-DPAT + PUR10 58.30 ± 0.221 #$ 7.52 ± 0.009 #$ 25.78 ± 0.223 #$ 43.71 ± 0.014 #$
7. 8-OH-DPAT + FLX10 50.01 ± 0.206 6.77 ± 0.009 23.08 ± 0.276 37.48 ± 0.014
8. 8-OH-DPAT + PUR10 + FLX10 42.05 ± 0.170 #@ 5.37 ± 0.009 #@ 21.22 ± 0.279 #@ 24.95 ± 0.008 #@

Statistical analysis followed by one-way ANOVA (post-hoc Tukey’s test). Values expressed as mean ± SEM (n = 6 rats per group). * p < 0.01 v/s vehicle control, sham control and PUR10 per se; # p < 0.01 v/s 8-OH-DPAT; #$ p < 0.01 v/s 8-OH-DPAT + PUR5;  p < 0.01 v/s 8-OH-DPAT + PUR5 and 8-OH-DPAT + PUR10; #@ p < 0.01 v/s 8-OH-DPAT + FLX10.